US – Utah: Senate Bill (SB) 137 was amended and passed by the House and must now be reconciled by the Senate before going to the governor for final approval. SB 137 would modify the state’s medical cannabis laws in several ways, including requiring terpene testing and disclosure of terpene profiles for certain products and extending the expiry date of initial issuances of » Continue Reading. ...
LATEST ALERTS
View all Read our latest free content
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
Your display name will appear here.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.